- Home
- Publications
- Publication Search
- Publication Details
Title
Immunity and immune suppression in human ovarian cancer
Authors
Keywords
-
Journal
Immunotherapy
Volume 3, Issue 4, Pages 539-556
Publisher
Future Medicine Ltd
Online
2011-04-04
DOI
10.2217/imt.11.20
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Macrophage Migration Inhibitory Factor Contributes to the Immune Escape of Ovarian Cancer by Down-Regulating NKG2D
- (2014) M. Krockenberger et al. JOURNAL OF IMMUNOLOGY
- Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
- (2014) J.-I. Youn et al. JOURNAL OF IMMUNOLOGY
- Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer
- (2010) Xin An et al. BIOMARKERS
- Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines
- (2010) Shiqian Zhang et al. BMC CANCER
- Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer
- (2010) N Leffers et al. BRITISH JOURNAL OF CANCER
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
- (2010) Suzanne Ostrand-Rosenberg CANCER IMMUNOLOGY IMMUNOTHERAPY
- Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes
- (2010) Juan R. Cubillos-Ruiz et al. CELL CYCLE
- A Degenerate HLA-DR Epitope Pool of HER-2/neu Reveals a Novel In vivo Immunodominant Epitope, HER-2/neu88-102
- (2010) L. Karyampudi et al. CLINICAL CANCER RESEARCH
- Farletuzumab, a Humanized Monoclonal Antibody against Folate Receptor , in Epithelial Ovarian Cancer: a Phase I Study
- (2010) J. A. Konner et al. CLINICAL CANCER RESEARCH
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: A case-matched comparison
- (2010) H.S. Kim et al. EJSO
- Pertuzumab for the treatment of ovarian cancer
- (2010) Simon P Langdon et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Farletuzumab in epithelial ovarian carcinoma
- (2010) Whitney A Spannuth et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer
- (2010) Hideaki Shimada et al. Gastric Cancer
- Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers
- (2010) Barbara Sperner-Unterweger et al. IMMUNOBIOLOGY
- The PD-1 pathway in tolerance and autoimmunity
- (2010) Loise M. Francisco et al. IMMUNOLOGICAL REVIEWS
- The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
- (2010) Markus M. Heiss et al. INTERNATIONAL JOURNAL OF CANCER
- Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer
- (2010) Pei-Rong Ding et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Ovarian Cancer Cells Induce Peripheral Mature Dendritic Cells to Differentiate Into Macrophagelike Cells In Vitro
- (2010) Fangxue Chen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Functional Activity of the OCT-1 Protein Is Predictive of Long-Term Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib
- (2010) Deborah L. White et al. JOURNAL OF CLINICAL ONCOLOGY
- Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel
- (2010) P. Hoskins et al. JNCI-Journal of the National Cancer Institute
- MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells
- (2010) Jennifer AA Gubbels et al. Molecular Cancer
- Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
- (2010) Jennifer A. Belisle et al. Molecular Cancer
- Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells
- (2010) S Bafna et al. ONCOGENE
- MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells
- (2010) M P Ponnusamy et al. ONCOGENE
- Tumor-infiltrating NY-ESO-1–specific CD8+T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
- (2010) Junko Matsuzaki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
- (2010) Jason A Wilken et al. Journal of Ovarian Research
- Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
- (2009) I. Kryczek et al. BLOOD
- B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
- (2009) R. A. Wilcox et al. BLOOD
- HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
- (2009) Jessica N McAlpine et al. BMC CANCER
- Overexpression of human sperm protein 17 increases migration and decreases the chemosensitivity of human epithelial ovarian cancer cells
- (2009) Fang-qiu Li et al. BMC CANCER
- In situ Stimulation of CD40 and Toll-like Receptor 3 Transforms Ovarian Cancer-Infiltrating Dendritic Cells from Immunosuppressive to Immunostimulatory Cells
- (2009) U. K. Scarlett et al. CANCER RESEARCH
- The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
- (2009) M. Munz et al. CANCER RESEARCH
- Tumor-Expressed B7-H1 and B7-DC in Relation to PD-1+ T-Cell Infiltration and Survival of Patients with Cervical Carcinoma
- (2009) R. Karim et al. CLINICAL CANCER RESEARCH
- Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival
- (2009) Mark J. Dobrzanski et al. CLINICAL IMMUNOLOGY
- Adoptive cell therapy for the treatment of patients with metastatic melanoma
- (2009) Steven A Rosenberg et al. CURRENT OPINION IN IMMUNOLOGY
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
- (2009) Makoto Miyara et al. IMMUNITY
- Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial
- (2009) Ninke Leffers et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I Active Immunotherapy With Combination of Two Chimeric, Human Epidermal Growth Factor Receptor 2, B-Cell Epitopes Fused to a Promiscuous T-Cell Epitope in Patients With Metastatic and/or Recurrent Solid Tumors
- (2009) Pravin T.P. Kaumaya et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
- (2009) Mary L. Disis et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
- (2009) Sharmila Makhija et al. JOURNAL OF CLINICAL ONCOLOGY
- Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
- (2009) Katy Milne et al. PLoS One
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
- (2008) K. Movahedi et al. BLOOD
- MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells
- (2008) M P Ponnusamy et al. BRITISH JOURNAL OF CANCER
- Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis
- (2008) Kui Li et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment
- (2008) HanByoul Cho et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
- (2008) Ninke Leffers et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- An HLA-DR-Degenerate Epitope Pool Detects Insulin-like Growth Factor Binding Protein 2-Specific Immunity in Patients with Cancer
- (2008) K. R. Kalli et al. CANCER RESEARCH
- MUC4, a Multifunctional Transmembrane Glycoprotein, Induces Oncogenic Transformation of NIH3T3 Mouse Fibroblast Cells
- (2008) S. Bafna et al. CANCER RESEARCH
- Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity
- (2008) E. Huarte et al. CANCER RESEARCH
- Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian Cancer
- (2008) M. J. Callahan et al. CLINICAL CANCER RESEARCH
- Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission
- (2008) C. S.M. Diefenbach et al. CLINICAL CANCER RESEARCH
- Dendritic cell subsets in the peritoneal fluid and peripheral blood of women suffering from ovarian cancer
- (2008) I. Wertel et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Folate receptor alpha as a tumor target in epithelial ovarian cancer
- (2008) Kimberly R. Kalli et al. GYNECOLOGIC ONCOLOGY
- Rationale for folate receptor alpha targeted therapy in “high risk” endometrial carcinomas
- (2008) Monica Brown Jones et al. INTERNATIONAL JOURNAL OF CANCER
- Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer
- (2008) Angèle L.M. Oei et al. INTERNATIONAL JOURNAL OF CANCER
- Reversal of Drug Resistance in Ovarian Cancer: Where Do We Go From Here?
- (2008) Stan B. Kaye JOURNAL OF CLINICAL ONCOLOGY
- A Multipeptide Vaccine is Safe and Elicits T-cell Responses in Participants With Advanced Stage Ovarian Cancer
- (2008) Kimberly A. Chianese-Bullock et al. JOURNAL OF IMMUNOTHERAPY
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA–MORAb-003
- (2008) Peter M. Smith-Jones et al. NUCLEAR MEDICINE AND BIOLOGY
- Ovarian Cancer Cells Modulate Human Blood Neutrophils Response to ActivationIn Vitro
- (2008) M. Klink et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- NKG2D ligands: key targets of the immune response
- (2008) Segundo González et al. TRENDS IN IMMUNOLOGY
- The NKG2D receptor: sensing stressed cells
- (2008) Carlos López-Larrea et al. TRENDS IN MOLECULAR MEDICINE
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started